Gene ID Number
7040
Modification Site
None
Crossreactivity
Human
Swiss Prot
P01137
Subcellular location
Secreted
Tested applications
IF(IHC-P)
French translation
anticorps
Target Antigen
TGF beta 1
Modification
Unmodified
Clonality
Polyclonal
Concentration
1ug per 1ul
Excitation emission
590nm/617nm
Immunogen range
100-150/390
Conjugated with
ALEXA FLUOR® 594
Conjugated
Alexa conjugate 1
Recommended dilutions
IF(IHC-P)(1:50-200)
Clone
Polyclonal antibody
Purification
Purified by Protein A.
Category
Conjugated Primary Antibodies
Conjugation
Alexa Fluor,ALEXA FLUOR® 594
Host Organism
Rabbit (Oryctolagus cuniculus)
Also known as
Anti-TGF beta 1 PAb ALEXA FLUOR 594
Specificity
This is a highly specific antibody against TGF beta 1.
Long name
TGF beta 1 Polyclonal Antibody, ALEXA FLUOR 594 Conjugated
Synonyms
CED; LAP; DPD1; TGFB; TGFbeta; Transforming growth factor beta-1; TGF-beta-1; TGFB1
Cross-reactive species details
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
Source
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human TGF beta 1/LAP
Storage conditions
Store this antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Keep refrigerated at 2 to 8 degrees Celcius for up to one year.
Properties
For facs or microscopy Alexa 1 conjugate.If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies. ALEXA FLUOR they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
Background of the antigen
Multifunctional protein that controls proliferation, differentiation and other functions in many cell types. Many cells synthesize TGFB1 and have specific receptors for it. It positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Can promote either T-helper 17 cells (Th17) or regulatory T-cells (Treg) lineage differentiation in a concentration-dependent manner. At high concentrations, leads to FOXP3-mediated suppression of RORC and down-regulation of IL-17 expression, favoring Treg cell development. At low concentrations in concert with IL-6 and IL-21, leads to expression of the IL-17 and IL-23 receptors, favoring differentiation to Th17 cells.